Gefitinib-loaded starch nanoparticles for battling lung cancer: Optimization by full factorial design and in vitro cytotoxicity evaluation
Lung cancer is the number one killer among all cancer types. For decades, clinicians have been using conventional chemotherapeutics, but they can’t rely on them alone anymore, because they poison bad cells and good cells as well. Researchers exploited nanotechnology as a potential tool to develop a...
Main Authors: | Haitham Amin, Shaaban K. Osman, Ahmed M. Mohammed, Gamal Zayed |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016422002730 |
Similar Items
-
Quality by design approach for the synthesis of graphene oxide nanosheets using full factorial design with enhanced delivery of Gefitinib nanocrystals
by: Mahesh P More, et al.
Published: (2021-01-01) -
Pyogenic Granuloma in a Patient on Gefitinib
by: António Fernandes Massa, et al.
Published: (2016-06-01) -
Factorial Design to Stimulate Biomass Development with Chemically Modified Starch
by: Olga Popa, et al.
Published: (2022-10-01) -
Severe stomatitis caused by osimertinib combined with gefitinib: A case report
by: Ya‐ning Zhu, et al.
Published: (2022-02-01) -
Response to Gefitinib in Pericardial Effusion Due to Lung Cancer
by: Norihiro Kikuchi, et al.
Published: (2003-01-01)